Alvin Farrel

11PUBLICATIONS

122CO-AUTHORS

Molecular targetsTumour immunologyGenomicsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Interactive narrative

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 13, 2026

The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.

|Jan 01, 2026

HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumors.

Daniel Hwang, Molly C Erdman, Santosh Adhikari

|Sep 02, 2025

The Open Pediatric Cancer Project.

Zhuangzhuang Geng, Eric Wafula, Ryan J Corbett

|Aug 06, 2025

The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity.

John Maris, Isabel Soria-Bretones, Matias Casás-Selves

|Feb 05, 2025

Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma.

Smita Matkar, Michael P East, Timothy J Stuhlmiller

|Jan 18, 2025

Lineage dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and -independent immunotherapeutic targets.

Nathan M Kendsersky, Michal Odrobina, Nathaniel W Mabe

Pageof 2

Frequent Collaborators

John Maris

David Groff

Jo Lynne Rokita

Yael P Mossé

Lea Surrey

Nathan M Kendsersky

Nikolaos G Sgourakis

Ryan J Corbett

Zhuangzhuang Geng

Peiyao Li

Frequent Collaborators

John Maris

David Groff

Jo Lynne Rokita

Yael P Mossé